Cellectis S.A. (CMVLF) Stock Analysis
DELISTED
What happened to Cellectis S.A. (CMVLF) stock?
Cellectis S.A. (CMVLF) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
Market cap $252M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Cellectis S.A. (CMVLF). Cellectis S.A. is a clinical-stage biotechnology company focused on developing allogeneic T-cell therapies for cancer. The company leverages gene-editing technologies to create CAR-T cell therapies targeting various hematologic malignancies and solid tumors.
Last analyzed: Mar 16, 2026Cellectis S.A. (CMVLF) Healthcare & Pipeline Overview
CMVLF OTC Market Information
CMVLF trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy CMVLF shares?
No. CMVLF stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for CMVLF elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before CMVLF stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Cellectis S.A.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.